Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03468426
Title A Study to Test Different Doses of BI 836880 Combined With Ezabenlimab in Patients With Advanced Non-small Cell Lung Cancer Followed by Other Types of Advanced Solid Tumours
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Boehringer Ingelheim
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | POL | GBR | FRA | ESP | DEU | AUS

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35249 United States Details
Beverly Hills Cancer Center Beverly Hills California 90211 United States Details
Winship Cancer Institute Atlanta Georgia 30322 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Huntsman Cancer Institute Salt Lake City Utah 84112 United States Details
Virginia Cancer Specialists, PC Fairfax Virginia 22031 United States Details
Royal North Shore Hospital-St Leonards-20807 St Leonards New South Wales 2065 Australia Details
Royal North Shore Hospital St Leonards New South Wales 2065 Australia Details
Westmead Hospital Westmead New South Wales 2145 Australia Details
Peninsula & South Eastern Oncology Group Frankston Victoria 3199 Australia Details
Alfred Hospital Melbourne Victoria 3004 Australia Details
CTR Georges-François Leclerc Dijon 21079 France Details
HOP Timone Marseille 13385 France Details
INS Curie Paris 75005 France Details
CTR Eugène Marquis Rennes 35042 France Details
HOP Nord Laennec Saint-Herblain 44800 France Details
HOP Civil Strasbourg 67091 France Details
Universitätsklinikum Augsburg Augsburg 86156 Germany Details
Universitätsklinikum Carl Gustav Carus Dresden Dresden 01307 Germany Details
Universitätsklinikum Frankfurt Frankfurt am Main 60528 Germany Details
Universitätsmedizin der Johannes Gutenberg-Universität Mainz Mainz 55131 Germany Details
Universitätsklinikum Regensburg Regensburg 93053 Germany Details
Queen Mary Hospital Hong Kong Hong Kong Details
Seoul National University Bundang Hospital Seongnam 13620 Korea, Republic of Details
Seoul National University Hospital Seoul 03080 Korea, Republic of Details
Asan Medical Center Seoul 05505 Korea, Republic of Details
University Clinical Center, Gdansk Gdansk 80-952 Poland Details
Mandziuk Slawomir Specialist Medical Practice Lublin 20-093 Poland Details
European Health Center Otwock Otwock 05-462 Poland Details
MED POLONIA SP Z O O, Clinical Trials Department,Poznan Poznan 60-693 Poland Details
Dom Lekarski S.A. Szczecin 70-784 Poland Details
JSC "Group of Companies "Medsi" Moscow 125284 Russian Federation Details
SBHI "Saint-Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncological)" St. Petersburg 197758 Russian Federation Details
State Budget Healthcare Institution "Volgograd Regional Clinical Oncology Dispensary" Volgograd 400138 Russian Federation Details
Hospital Vall d'Hebron-Barcelona-47683 Barcelona 08035 Spain Details
Hospital Vall d'Hebron Barcelona 08035 Spain Details
Hospital Clínic de Barcelona Barcelona 08036 Spain Details
Hospital Clínico de Valencia Valencia 46010 Spain Details
NCKUH Tainan 704 Taiwan Details
National Taiwan University Hospital Taipei 100 Taiwan Details
Municipal Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council Dnipropetrovks 49102 Ukraine Details
Kyiv City Clinical Oncological Center Kyiv 3115 Ukraine Details
Medical and Preventive Treatment Inst. Volyn Regional, Lutsk Lutsk 43018 Ukraine Details
Vinnytsia Regional Clinical Oncological Dispensary Vinnytsia 21029 Ukraine Details
Royal Free Hospital London NW3 2QG United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field